2025 Interdisciplinary Gastrointestinal Oncology Update: A Case-Based Approach

THIS CONFERENCE HAS BEEN POSTPONED. PLEASE CHECK BACK FOR UPDATES.

Questions related to the course postponement: email [email protected]

A group of clinical leaders across multiple disciplines including surgery, radiation oncology, nuclear medicine and medical oncology, will provide updates in the management of patients with gastrointestinal malignancies. Through a case-based approach, learners will gain insight into, but not limited to: Management of localized rectal cancer, including dMMR Role of liver transplant in metastatic colorectal cancer Role of PRRT in patients with metastatic neuroendocrine tumors Role of ctDNA in GI cancers Management of localized gastroesophageal cancers

Friday, February 28, 2025, 7:00 AM - 3:45 PM EST, The Forum Hotel, Charlottesville, VA

1. Discuss the role of transplant in patients with metastatic colorectal cancer.
2. Explain the role of Circulating tumor DNA (dtDNA) in managing patients with GI malignancies.
3. Describe the role of targeted therapy in patients with cholangiocarcinoma
4. Explain the role of Peptide receptor radionuclide therapy (PRRT) in patients with advanced neuroendocrine tumors.

AMA PRA Category 1 Credits™ (6.00 hours), ANCC Contact Hours (6.00 hours), Hours of Participation (6.00 hours)

Participant Fees:

Participant Fees:	Thru 1/29/2025	After 1/29/2025
Physician	$175	$225
Non-physician	$90	$115
Fellow/Resident/Med Student*	No charge	No charge

*Documentation Required
Email [email protected] for registration code

Cancellation Policy

Cancellation requests received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be provided for cancellation requests received within 30 days or for registration fees of less than $50.  Please send cancellation requests [email protected].

 

UVA Health Continuing Education reserves the right to cancel CE activities if necessary.  In this case, the entire registration fee will be refunded.  All other expenses incurred in conjunction with this CE activity are the sole responsibility of the participant.

Accessibility Statement
 
UVACE is committed to ensuring equal access to educational opportunities for individuals with disabilities, in compliance with the Americans with Disabilities Act of 1990 (ADA), as amended, and Section 504 of the Rehabilitation Act of 1973 (Section 504), as well as other applicable state and local laws and University policy. Individuals with disabilities are entitled to reasonable accommodations to ensure their participation in courses. Please note that some of the course venues at UVA are registered historic properties and may not be fully ADA accessible. If you have needs that require special accommodation, including dietary concerns, please email [email protected].  All requests must be received 30 days prior to the course start date.

In support of improving patient care, the University of Virginia School of Medicine and School of Nursing is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mitigation of Relevant Financial Relationships

UVA Health Continuing Education adheres to the to the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

To view financial disclosures, select the faculty name below.

 

Friday, February 28, 2025